Sea Moss and Inflammation: How Fucoidan Inhibits NF-κB

Inflammation is not a single event — it's a signaling cascade controlled largely by a transcription factor called NF-κB. When NF-κB is activated, it switches on genes for pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Fucoidan in sea moss directly inhibits NF-κB activation in multiple cell types.

The NF-κB Mechanism

Under normal conditions, NF-κB is held inactive by IκB (inhibitor of κB). Inflammatory triggers — bacterial toxins, oxidative stress, cytokines — activate IKK (IκB kinase), which phosphorylates IκB, marking it for degradation. This releases NF-κB to enter the nucleus and activate inflammatory genes. Fucoidan's sulfated polysaccharide structure interferes with IKK activation, preventing IκB degradation and keeping NF-κB inactive. This has been demonstrated in macrophages, endothelial cells, and synoviocytes in cell culture systems.

What This Means Practically

Reduced NF-κB activation means reduced production of: TNF-α (drives systemic inflammation and joint destruction), IL-6 (acute phase response, fever, CRP elevation), and IL-1β (local tissue inflammation and pain signaling). In joint pain, this is particularly relevant — synoviocytes (cells lining joint capsules) express NF-κB in response to mechanical stress and injury, and fucoidan has shown reduced IL-1β output from these cells in vitro.

The Carrageenan Question

Carrageenan in sea moss has a complicated reputation: degraded carrageenan (poligeenan, MW <50 kDa) causes intestinal inflammation in animal models. Native carrageenan in whole sea moss is a larger molecule (MW >200 kDa) that the gut cannot absorb intact. The inflammation research used degraded carrageenan — not the molecule present in food-grade sea moss.